EDGAR Filing Documents for 0001437749-15-015758

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001437749-15-015758

Filing Date

2015-08-13

Accepted

2015-08-13 16:54:32

Documents

Period of Report

2015-08-11

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 4	rdgdoc.html	4
1	FORM 4	rdgdoc.xml	4	3555
	Complete submission text file	0001437749-15-015758.txt		5344

Mailing Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009

Business Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009 301-770-3099

Biota Pharmaceuticals, Inc. (Issuer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 175 CROSSING BOULEVARD FRAMINGHAM MA 01702

Business Address

COX GEOFFREY F (Reporting) CIK: 0001021014 (see all company filings)

State of Incorp.: MA | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-35285 | Film No.: 151051378
SIC: 2836 Biological Products, (No Diagnostic Substances)